ECT2 and lung adenocarcinoma: In a KRAS-TRP53-driven lung adenocarcinoma model (LDAC), it has been demonstrated that the nuclear GEF activity of Ect2 is indispensable for maintaining tumor-initiating cells (TICs), and the transformative effects mediated by Ect2 rely on Ect2-associated rDNA transcription.